Posts Tagged ‘restylane’

FDA Advisory Panel Recommends Restylane for Lip Enhancement

Monday, May 9th, 2011

While an advisory panel to the Food and Drug Administration (FDA) injectable filler Restylane for lip enhancement, it seems unlikely to make much difference even if the FDA does move to approval. Many doctors in the United States already find Restylane very effective in filling out their patients’ lips.

Restylane, like other hyaluronic acid fillers such as Juvederm and Elevess, temporarily smooths wrinkles by adding volume under the skin, and was approved for this use by the FDA in 2003. The effects of hyaluronic acid fillers typically last about six months.

Restylane is frequently used for off-label purposes, such as lip augmentation, since hyaluronic acid occurs naturally in the body and there are very few risks associated with the procedure. According to Dr. Farhad Rafizadeh, a New Jersey plastic surgeon who spoke with MyHealthNewsDaily, Restylane is the best filler for the lips because it remains in place. Other facial fillers, he says, tend to seep into other areas of the face.

This practice is not as unusual as one might think, since off-label use for a product is quite different from using a substance that has not been approved by the FDA. Experienced, conscientious doctors can legally and ethically use drugs and other products for alternative purposes, as long as these products have already been shown to be safe for human use, and the patient fully understands the nature of the use.

A move by the FDA to approve hyaluronic acid fillers for lip enhancement would most likely only impact doctors that are unaccustomed to using the products and hesitate to go off the beaten path. In the hands of an expert plastic surgeon, however, hyaluronic acid fillers can work wonders for smile lines, wrinkles, creases, lips, and hollow cheeks.

Facial Plastic Surgery Stats Show Increase in Non Invasive Treatments

Thursday, February 24th, 2011

Statistics about facial cosmetic treatments show that in 2010, about 75 percent of the procedures performed were non-surgical, which may confirm an often discussed trend toward non-surgical cosmetic treatments.

The stats come straight from the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), and they show a 45 percent increase in the number of facial procedures performed over the last two years, representing a 16 percent annual increase in non-surgical facial procedures.

“Non-surgical procedures are an excellent option for some people, with the added benefits of lower costs and shorter recovery time; two things that are consistently important to those considering facial plastic surgery,” said Dr. Jonathan M. Sykes. “We have been seeing a trend over the past few years that people who want to look and feel younger and rejuvenated are turning to non-surgical, less invasive procedures to obtain the refreshed look they want.”

Based on the AAFPRS survey, the hot procedures of 2010 were non-surgical procedures like Botox and Restylane injections. Among surgical procedures, the most popular were rhinoplasty, facelift and eyelid surgery.

Females received the majority of facial procedures in 2010 (83 percent), but the most popular procedures varied by age. For women 35 to 60, the top surgical procedures were brow lift, facelift and eyelid surgery, while a nose job was the top surgical procedure performed on women under 35. Botox, injectable fillers nose jobs, and hair transplants were the most common facial procedures performed on men in 2010.

The AAFPRS survey also reported an increase in ethnic patients: two out of five surgeons said they had an increase in their Asian American and Hispanic patients last year.

You can read more of these survey results at

Swiss Pharmaceutical Seeks to Acquire Restylane Manufacturer

Tuesday, December 14th, 2010

The latest news from say that Q-Med, the Swedish manufacturer of Restylane wrinkle filler, is likely to be acquired by the Swiss pharmaceutical company Galderma.

Galderma is known for making the popular Cetaphil products. The dermatology-focused pharmaceutical company was founded over 25 years ago, and is currently owned by L’Oreal and Nestle.

Q-Med makes the popular Restylane dermal filler, which was introduced in the mid 90s. Earlier this year, the company announced a new line of skincare products made with their patented NASHA gel, which is not currently available in the U.S.

In the United States, Medicis Pharmaceutical is licensed to distribute Restylane, along with Perlane, Dysport and other cosmetic products. According to the most recent updates from Bloomberg, Galderma’s offer to acquire Q-Med is conditional on approval from Medicis. On their corporate website, you can read about the and their partnership with Q-Med.

Call us at or contact us online to schedule your consultation today.